Four telemedicine platforms fold, one month into Korea’s pilot program
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
This is because, industry insiders said, added conditions, such as limiting telemedicine to follow-up visits and prohibiting the delivery of medicines, made it more inconvenient than the non-face-to-face care provided during the pandemic and causing a surge in people avoiding the service itself. There are growing concerns that if this trend continues, the government’s initial goal of promoting telemedicine may not take hold.
According to industry sources on Monday, since the pilot program began on June 1, four of the 30 domestic platform companies - Sir’s, FADOC, Baropill and Chekit - have suspended or closed their operations. Other companies such as thebestdoc and MO are also planning to terminate their services soon.
Industry insiders attributed the decline in the number of users to the fact that the service is limited to follow-up visits and that prescription drugs can only be picked up by going to a pharmacy where they can be dispensed.
In fact, Goodoc experienced a drop of about 95 percent in the average daily number of non-face-to-face consultations in July compared to May. During the same period, Doctor Now also saw a 26.8 percent decrease in the number of consultations.
In May, an average of over 5,000 consultations were conducted daily, but this month, it has dropped to around 3,600. As a result, the cancellation rate of medical appointments has noticeably increased. Not only are patients skeptical about non-face-to-face consultation services, but hospitals are also reluctant to use telemedicine, resulting in a significant drop in the overall number of remote consultations.
According to Doctor Now, the average appointment cancellation rate this month stands at 38.3 percent, more than three times higher than 11 percent in May. For My Doctor, the rate of failure to connect to an actual consultation has increased by about twofold during the same period. Specifically, the refusal rate for patients with colds increased to 30 percent in July from 10 percent in May, and for patients with chronic diseases such as hypertension and diabetes to 40 percent in July from 18 percent in May.
“The government seems to be attaching significance to the fact that non-face-to-face medical treatment, which has only been discussed for 30 years, has led to a pilot project, but the industry is worried that if the situation continues like this, all platform companies may close down and the market itself may disappear altogether,” said an industry insider.
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- “여자가 옷 벗고 돌아다닌다”…출동 경찰 집에 가보니 ‘충격적 장면’ - 매일경제
- ‘에코프로도 울고 간다’…1년 만에 20배 폭등한 이 종목 - 매일경제
- “30만원 조용히 계산”…군인 4명 음식값 대신 낸 중년 男 - 매일경제
- “그냥 쏘렌토 살걸, 괜히 기다렸다”…‘확 바뀐’ 싼타페, 아빠는 괴롭다 [카슐랭] - 매일경제
- [단독] 선진국선 좋다고 난리인데…한국은 병원도 환자도 거부, 왜? - 매일경제
- “다른 곳에 주차”…종이 박스에 적힌 이유 ‘실소’ - 매일경제
- 오직 외국인 관광객만 쓸 수 있다는 일본의 교통카드 실체 - 매일경제
- 위험천만 오송 지하차도서 3명 목숨 구한 화물차 기사 - 매일경제
- 앞다퉈 해변 비치 클럽 오픈한 명품 브랜드…대체 무슨 일이 - 매일경제
- 섬머리그 마치고 호주로 향하는 이현중 “긴 과정 거치는 중, 지켜봐달라” - MK스포츠